Patent ID: 11925637
Assignee: SRX CARDIO, LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 15:
16. The method of claim 10, wherein the compound is selected from the group, consisting of:
N-phenyl-4-(piperazin-1-yl)benzenesulfonamide;
N-isopropyl-4-((4-(piperazin-1-yl)phenyl)sulfonamido)benzamide;
N-methyl-4-((4-(piperazin-1-yl)phenyl)sulfonamido)benzamide;
N-(3,4-dimethylphenyl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(3,5-dimethylphenyl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(3,5-dichlorophenyl)-4-(piperazin-1-yl)benzenesulfonamide;
4-(piperazin-1-yl)-N-(5,6,7,8-tetrahydronaphthalen-2-yl)benzenesulfonamide;
N-(naphthalen-2-yl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(cinnolin-7-yl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(isoquinolin-7-yl)-4-(piperazin-1-yl)benzenesulfonamide;
4-(piperazin-1-yl)-N-(quinolin-6-yl)benzenesulfonamide;
N-(cinnolin-6-yl)-4-(piperazin-1-yl)benzenesulfonamide;
4-(piperazin-1-yl)-N-(quinoxalin-6-yl)benzenesulfonamide;
4-(piperazin-1-yl)-N-(pyrido[2,3-b]pyrazin-7-yl)benzenesulfonamide;
N-(1H-benzo[d][1,2,3]triazol-5-yl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(2-methylbenzo[b]thiophen-5-yl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(benzo[c][1,2,5]thiadiazol-5-yl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(1H-indol-6-yl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(1H-indol-5-yl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(benzo[d]isoxazol-5-yl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(2-aminoimidazo[1,2-a]pyrimidin-6-yl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(2,3-dihydrobenzofuran-6-yl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(2,3-dihydrobenzofuran-5-yl)-4-(piperazin-1-yl)benzenesulfonamide;
N-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-4-(piperazin-1-yl)benzenesulfonamide;
2-hydroxy-N-phenyl-4-(piperazin-1-yl)benzenesulfonamide;
4-(2-oxopiperazin-1-yl)-N-phenylbenzenesulfonamide;
2-fluoro-4-(2-oxopiperazin-1-yl)-N-phenylbenzenesulfonamide;
N-phenyl-4-(piperazin-1-yl-2,2,6,6-d4)benzenesulfonamide;
N-phenyl-4-(piperidin-4-yl)benzenesulfonamide;
4-(piperidin-4-yl)-N-(5,6,7,8-tetrahydronaphthalen-2-yl)benzenesulfonamide;
4-(piperazin-1-yl)-N-(pyridin-4-yl)benzenesulfonamide;
4-(piperazin-1-yl)-N-(pyridin-3-yl)benzenesulfonamide;
4-(piperazin-1-yl)-N-(pyridin-2-yl)benzenesulfonamide;
4-(piperazin-1-yl)-N-(thiazol-2-yl)benzene sulfonamide;
4-(piperazin-1-yl)-N-(quinolin-7-yl)benzenesulfonamide;
N-phenyl-6-(piperazin-1-yl)pyridine-3-sulfonamide;
N-phenyl-5-(piperazin-1-yl)pyridine-2-sulfonamide;
N-(3,5-difluorophenyl)-4-(piperazin-1-yl)benzenesulfonamide;
3-fluoro-4-(piperazin-1-yl)-N-(5,6,7, 8-tetrahydronaphthalen-2-yl)benzenesulfonamide;
6-(piperazin-1-yl)-N-(5,6,7,8-tetrahydronaphthalen-2-yl)pyridine-3-sulfonamide;
5-(piperazin-1-yl)-N-(5,6,7,8-tetrahydronaphthalen-2-yl)pyridine-2-sulfonamide;
N-phenyl-4-(piperidin-4-yl)benzenesulfonamide; and
4-(piperidin-4-yl)-N-(5,6,7,8-tetrahydronaphthalen-2-yl)benzene sulfonamide;
or a pharmaceutically acceptable salt thereof.